Biospring Partners
Biospring Partners is a growth equity firm, founded in 2020 and headquartered in New York City, that invests in growth-stage B2B companies across life sciences technology. The firm builds long-term partnerships with management teams and provides capital plus portfolio-level value creation support focused on scaling companies in sectors such as pharma services, biomanufacturing, cell & gene therapy, digital health, and life-sciences software.
Biospring Partners
Services
Growth equity capital
Provides growth-stage equity investments to B2B companies in life sciences technology.
Portfolio management and value creation
Dedicated portfolio management function to monitor performance, design value-creation plans, and optimize exit timing; led by Head of Portfolio Management.
Access to operating partners and operational expertise
Engages operating partners and industry experts to support portfolio companies on functions such as corporate development, technology, regulatory and manufacturing themes (examples: operating partners recruited from portfolio and pharma services industry).
Advisory board and industry network
Provides portfolio companies access to an advisory board composed of senior industry and academic leaders across pharma, finance, and technology.
Market and technical resources (research, primers, webinars)
Publishes sector primers, interviews, and panel discussions on themes such as biomanufacturing, radiopharma, AI in drug discovery and cell & gene therapy to inform portfolio strategy and market positioning.
Growth equity capital
Provides growth-stage equity investments to B2B companies in life sciences technology.
Portfolio management and value creation
Dedicated portfolio management function to monitor performance, design value-creation plans, and optimize exit timing; led by Head of Portfolio Management.
Access to operating partners and operational expertise
Engages operating partners and industry experts to support portfolio companies on functions such as corporate development, technology, regulatory and manufacturing themes (examples: operating partners recruited from portfolio and pharma services industry).
Advisory board and industry network
Provides portfolio companies access to an advisory board composed of senior industry and academic leaders across pharma, finance, and technology.
Market and technical resources (research, primers, webinars)
Publishes sector primers, interviews, and panel discussions on themes such as biomanufacturing, radiopharma, AI in drug discovery and cell & gene therapy to inform portfolio strategy and market positioning.
Portfolio
Offers discovery, development and cGMP manufacturing for biologics, ADCs; facilities in Cambridge UK, San Diego (500L–2000L bioreactors) and Bristol, PA; >400 projects referenced.
#CDMO / Contract development and manufacturing services for biologics and ADCs
Provides discovery, development and manufacturing services for cell and gene therapies; expertise in iPSCs.
#Cell & Gene Therapy manufacturing / CGT aggregator
Builds infrastructure and software for accessible, affordable health testing programs used by enterprises and service organizations.
#Health testing platforms / Telehealth-enabled testing programs
Platform connecting researchers with suppliers to improve visibility and insight into life-science supply chains.
#Life-science procurement / e-commerce for reagents and instrumentation
AI-based pathology platform aimed at improving diagnosis for clinical trials; leadership includes Dr. Andrew Beck (CEO).
#Pathology AI / Diagnostics
Full-service clinical trial provider partnering with community clinics to enable access to trials (Dallas/Ft. Worth market referenced).
#Clinical research / Outsourced clinical trial site services
Offers discovery, development and cGMP manufacturing for biologics, ADCs; facilities in Cambridge UK, San Diego (500L–2000L bioreactors) and Bristol, PA; >400 projects referenced.
#CDMO / Contract development and manufacturing services for biologics and ADCs
Provides discovery, development and manufacturing services for cell and gene therapies; expertise in iPSCs.
#Cell & Gene Therapy manufacturing / CGT aggregator
Builds infrastructure and software for accessible, affordable health testing programs used by enterprises and service organizations.
#Health testing platforms / Telehealth-enabled testing programs
Platform connecting researchers with suppliers to improve visibility and insight into life-science supply chains.
#Life-science procurement / e-commerce for reagents and instrumentation
AI-based pathology platform aimed at improving diagnosis for clinical trials; leadership includes Dr. Andrew Beck (CEO).
#Pathology AI / Diagnostics
Full-service clinical trial provider partnering with community clinics to enable access to trials (Dallas/Ft. Worth market referenced).
#Clinical research / Outsourced clinical trial site services